For patients focused on body recomposition, particularly visceral fat reduction alongside lean mass preservation, Tesamorelin offers a clinical evidence base that other peptides in this category cannot match
It is what the evidence actually supports, and where a nutrient injection still fits now that GLP-1 agonists exist
Anemia: Especially B12-deficiency anemia can improve with Neurobion injectable therapy
two published tirzepatide case series (Naranjo "probable"), FAERS reporting odds ratio 22.55 for allodynia across GLP-1 with tirzepatides neuro-AE proportion lower than semaglutides, class cohort signal (aHR 2.15) in related agents
Peptide Therapy: Addresses multiple hormone pathways simultaneously, potentially improving growth hormone, insulin-like growth factor, and other critical signaling molecules alongside testosterone optimization